For reasons including downsizing, avoiding retirement and a tight labor market, senior-level biopharma professionals are increasingly turning to fractional roles, according to two recruitment experts.| BioSpace
Employed and unemployed biotech and pharma professionals are thinking about job hunting in other fields amidst a challenging labor market.| BioSpace
Companies are announcing significant investments in U.S. manufacturing in response to looming tariffs. An AstraZeneca executive and Eli Lilly and Novo Nordisk spokespeople discuss potential job and skill-building opportunities and where manufacturing might head in the future.| BioSpace
External titles can create challenges for HR teams. Discover best practices for managing unofficial, external titles that minimize legal risk| CompTool